Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente

  1. Voltar
  2. Portal de Boas Práticas
  3. Atenção ao Recém Nascido
  4. Leite Materno como Imunoterapia

Postagens

Leite Materno como Imunoterapia

23 jun 2026

Postagem de 25 ago. 2023 | Atualizada em 23 jun. 2026

Definição: administração de leite materno, seja colostro, leite de transição ou maduro, diretamente na mucosa oral/nasal de todo recém-nascido internado na UNIDADE NEONATAL, independente da administração da dieta, até que o mesmo esteja mamando no peito materno.

Objetivos dessa apresentação:

  • Apresentar os benefícios do uso do leite materno como imunoterapia (imunoterapia oral ou lactoimunoterapia)
  • Compartilhar informações sobre os processos facilitadores da ordenha precoce
  • Orientar a construção de processos de trabalho para garantia da extração beira-leito do leite materno e a oferta do leite cru nas primeiras 12 horas após a extração

Skip to PDF content

Referências citadas:

  • Linnér, A, Lode Kolz, K, Klemming, S, et al. Immediate skin-to-skin contact may have beneficial effects on the cardiorespiratory stabilisation in very preterm infants. Acta Paediatr. 2022; 111: 1507–1514. doi:10.1111/apa.16371
  • Snyder R, et al., Early provision of oropharyngeal colostrum leads to sustained breast milk feedings in preterm infants, Pediatrics and Neonatology (2017), http://dx.doi.org/10.1016/j.pedneo.2017.04.003XXX
  • Bashir T, Reddy KV, Kiran S, Murki S, Kulkarni D, Dinesh P. Effect of colostrum given within the 12 hours after birth on feeding outcome, morbidity and mortality in very low birth weight infants: a prospective cohort study. Sudan J Paediatr. 2019;19(1):19–24. https://doi.org/10.24911/SJP.106-1540825552
  • Rodriguez NA, Vento M, Claud EC, Wang CE, Caplan MS. Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial. Trials. 2015 Oct 12;16:453. doi: 10.1186/s13063-015-0969-6. PMID: 26458907; PMCID: PMC4603349.
  • da Cruz Martins C, de Santana Xavier Ramos M, Viana Cardoso Amaral M, Santos Passos Costa J, Souza Cerqueira E, de Oliveira Vieira T, dA Cruz SS, Oliveira Vieira G. Colostrum oropharyngeal immunotherapy for very low birth weight preterm infants: protocol of an intervention study. BMC Pediatr. 2020 Aug 7;20(1):371. doi: 10.1186/s12887-020-02266-8. PMID: 32767992; PMCID: PMC7411269.
  • Huo M, Liu C, Mei H, Zhang Y, Liu C, Song D, Zhang Y, Zhang Y, Xin C. Intervention Effect of Oropharyngeal Administration of Colostrum in Preterm Infants: A Meta-Analysis. Front Pediatr. 2022 Jun 27;10:895375. doi: 10.3389/fped.2022.895375. PMID: 35832583; PMCID: PMC9271762.
  • Nasuf AWA, Ojha S, Dorling J. Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2018 Sep 7;9(9):CD011921. doi: 10.1002/14651858.CD011921.pub2. PMID: 30191961; PMCID: PMC6513592.
  • Fiocruz. RBLH. Normas Técnicas. NT 47.18 Uso do Leite Humano Cru Exclusivo em Ambiente Neonatal V. 1, N. 47, junho, 2018.
  • Fiocruz. Normas Técnicas. BLH-IFF/NT 54.21 Porcionamento do Leite Humano Ordenhado em Ambiente Hospitalar. V.1, N.54, setembro, 2021.
  • Hill PD, Aldag JC, Chatterton RT, Zinaman M. Primary and secondary mediators’ influence on milk output in lactating mothers of preterm and term infants. J Hum Lact. 2005 May;21(2):138-50. doi: 10.1177/0890334405275403. PMID: 15886340.
  • Ma A, Yang J, Li Y, Zhang X, Kang Y. Oropharyngeal colostrum therapy reduces the incidence of ventilator-associated pneumonia in very low birth weight infants: a systematic review and meta-analysis. Pediatr Res. 2021 Jan;89(1):54-62. doi: 10.1038/s41390-020-0854-1. Epub 2020 Mar 30. PMID: 32225172; PMCID: PMC7223528.
  • Fu ZY, Huang C, Lei L, Chen LC, Wei LJ, Zhou J, Tao M, Quan MT, Huang Y. The effect of oropharyngeal colostrum administration on the clinical outcomes of premature infants: A meta-analysis. Int J Nurs Stud. 2023 Aug;144:104527. doi: 10.1016/j.ijnurstu.2023.104527. Epub 2023 May 19. PMID: 37295286.
  • Parker MG, Melvin P, Graham DA, Gupta M, Burnham LA, Lopera AM, Zera CA, Belfort MB. Timing of First Milk Expression to Maximize Breastfeeding Continuation Among Mothers of Very Low-Birth-Weight Infants. Obstet Gynecol. 2019 Jun;133(6):1208-1215. doi: 10.1097/AOG.0000000000003258. PMID: 31135736.
  • Sudeep KC, Kuma J, Ray S, Dutta S, Aggarwal R, Kumar P. Oral Application of Colostrum and Mother’s Own Milk in Preterm Infants—A Randomized, Controlled Trial. Indian Journal of Pediatrics. 10 January 2022. https://doi.org/10.1007/s12098-021-03982-4
  • Abd-Elgawad M, Eldegla H, Khashaba M, Nasef N. Oropharyngeal Administration of Mother´s Milk Prior to Gavage Feeding in Preterm Infants: A Pilot Randomized Control Trial. Journal of Parenteral and Enteral Nutrition. 06 may 2019. https://doi.org/a0.1002/jpen.
  • Hellström S Linden K, Sengpiel V and Elfvin A. Implementing a colostrum-kit reduces the time to first colostrum for neonates admitted to the NICU – a retrospective observational study. International Breastfeeding Journal (2024) 19:77 https://doi.org/10.1186/s13006-024-00682-5
  • Martins CA, Ramos MX, Lyrio AO, Vieira TO, Cruz SS, Vieira GO. Oropharyngeal colostrum immunotherapy and risk reduction of mortality in very low birth weight premature e newborns: a clinical trial. Jornal de Pediatria 2024;100(1): 32 39
  • Wang N,  Hu Y,  Qiu W, He M,  Zang Q,  Wang B,  Tang B, Zhang H, Ni P,  Zhu S, and Zhang J.International Breastfeeding Journal Open Access Impact of colostrum oropharyngeal immunotherapy on postnatal growth in preterm infants based on early gut microbiota–host interaction patterns: protocol for a randomized controlled trial. International Breastfeeding Journal https://doi.org/10.1186/s13006-025-00769-7 STUDY PROTOCOL (2025) 20:72
  • Lamsehchi A, Solgi MS, Sabzehei MK, Basiri B,  Ghane ET, Asadi KK, Azadnajafabad S, Short-term outcomes of oropharyngeal administration of colostrum in preterm neonates: a double-blind placebo controlled randomized trial. Clin Exp Pediatr Vol. 68, No. 1, 73–79, 202. https://doi.org/10.3345/cep.2024.00591
  • Behrooj N, Hossein-Ali Nikbakht PA, Rad ZA & Zabihi A. Investigating the effect of oropharyngeal colostrum in the prevention of late-onset sepsis in preterm infants: a randomized controlled trial. Nature Portfolio – Scientific Reports | (2025) 15:17390 | https://doi.org/10.1038/s41598-025-02309-z
  • Sonmez Demir G, Ozdemir O M, Turgut M, et al. (March 11, 2025) Impact of Intranasal Administration of Fresh Breast Milk in Very Low Birth Weight Infants With Germinal Matrix-Intraventricular Hemorrhage. Cureus 17(3): e80416. DOI 10.7759/cureus.80416
  • Xiu W, Yang C, Lin X, Zhang B and Chen R (2025) Influence of oropharyngeal therapy with mother’s own milk on the microbiome and metabolome of very preterm infants: a pilot study. Front. Nutr. 2025. 12:1647379. doi: 10.3389/fnut.2025.1647379
  • Yücel A,  Küçükoğlu S,  Konak M. Effect of intranasal breast milk administration on cerebral oxygenation, vital signs, and transition time to full oral feeding in preterm infants: a randomized controlled study. European Journal of Pediatrics (2026) 185:272 https://doi.org/10.1007/s00431-026-06922-6
  • Parker MG, Stellwagen L, Miller ER, et al; American Academy of Pediatrics, Committee on Fetus and Newborn; Section on Breastfeeding; Committee on Nutrition. Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant: Clinical Report. Pediatrics. 2025;157(2):e2025073625 doi: 10.1186/s13006-025-00769-7 STUDY PROTOCOL (2025) 20:72

 

Conteúdo Relacionado

 

Como citar

FUNDAÇÃO OSWALDO CRUZ. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente. Postagens: Leite Materno como Imunoterapia. Rio de Janeiro, 23 jun. 2026. Disponível em: <https://portaldeboaspraticas.iff.fiocruz.br/atencao-recem-nascido/leite-materno-como-imunoterapia>.

 

Tags: Novembro Roxo Prematuridade

Busca

Mais conteúdo

Assuntos do Portal